Financhill
Sell
37

OTLC Quote, Financials, Valuation and Earnings

Last price:
$0.10
Seasonality move :
-0.41%
Day range:
$0.09 - $0.10
52-week range:
$0.02 - $0.11
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.59x
Volume:
118K
Avg. volume:
231.5K
1-year change:
190.85%
Market cap:
$41.5M
Revenue:
--
EPS (TTM):
-$0.00

Earnings Data

Next earnings date for OTLC
--
Most recent earnings per share
-$0.00
Missed by $0.00
(Sep 30/2025)
Consensus Estimate
--
(Sep 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

OTLC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 -- -- -$0.00 -- --
06/30/2025 Q2 -- -- $0.00 -- --
05/15/2025 Q1 -- -- -$0.00 -- --
12/31/2024 Q4 -- -- -$0.00 -- --
11/19/2024 Q3 -- -- -$0.01 -- --
08/14/2024 Q2 -- -- -$0.00 -- --
05/15/2024 Q1 -- -- -$0.00 -- --
12/31/2023 Q4 -- -- -$0.00 -- --
11/15/2023 Q3 -- $70K $0.00 -- --
06/30/2023 Q2 -- -- -$0.02 -- --
03/31/2023 Q1 -- -- -$0.00 -- --
12/31/2022 Q4 -- -- -$0.01 -- --
09/30/2022 Q3 -- -- -$0.00 -- --
06/30/2022 Q2 -- -- $0.04 -- --
03/31/2022 Q1 -- -- -$0.01 -- --
12/31/2021 Q4 -- -- -$0.00 -- --
09/30/2021 Q3 -- -- -$0.00 -- --
06/30/2021 Q2 -- -- -$0.01 -- --
03/31/2021 Q1 -- -- -$0.03 -- --
12/31/2020 Q4 -- -- -$0.04 -- --
09/30/2020 Q3 -- -- -$0.02 -- --
06/30/2020 Q2 -- $1.4M $0.01 -- --
03/31/2020 Q1 -- $340.9K -$0.05 -- --
12/31/2019 Q4 -- -- -$0.04 -- --
09/30/2019 Q3 -- -- -$0.01 -- --
06/30/2019 Q2 -- -- -$0.02 -- --
03/31/2019 Q1 -- -- -$0.14 -- --
12/31/2018 Q4 -- -- -$0.02 -- --
11/14/2018 Q3 -- -- -$0.04 -- --
06/30/2018 Q2 -- -- -$0.03 -- --
04/16/2018 Q1 -- -- -$0.03 -- --
12/31/2017 Q4 -- -- -$0.09 -- --
11/14/2017 Q3 -- -- -$0.13 -- --
08/02/2017 Q2 -- -- -$0.15 -- --
05/08/2017 Q1 -- -- -$0.15 -- --
12/31/2016 Q4 -- -- -$0.13 -- --
11/14/2016 Q3 -- -- -$0.12 -- --
08/03/2016 Q2 -- -- -$0.14 -- --
05/09/2016 Q1 -- -- -$0.13 -- --
03/28/2016 Q4 -- -- -$0.15 -- --

Oncotelic Therapeutics, Inc. Earnings Questions

  • How Much did Oncotelic Therapeutics, Inc. Generate in Revenue Last Quarter?

    Oncotelic Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Oncotelic Therapeutics, Inc. Beat Earnings Last Quarter?

    Oncotelic Therapeutics, Inc. announced earnings per share of -$0.00 which represents a miss of analyst forecast a -- per share.

  • Is Oncotelic Therapeutics, Inc. Profitable?

    Oncotelic Therapeutics, Inc. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Oncotelic Therapeutics, Inc. EPS Next Year?

    Oncotelic Therapeutics, Inc.'s earnings are forecast to grow from -$0.01 per share to -- per share next year representing an increase of --.

  • When is Oncotelic Therapeutics, Inc.'s Earnings Date?

    Currently, Oncotelic Therapeutics, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 9, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 65.66% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 9.94% over the past day.

Sell
13
PSN alert for Dec 8

Parsons Corp. [PSN] is down 4.41% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock